BBR Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.5M | Sell |
53,615
-2
| -0% | -$430 | 0.63% | 20 |
|
|
2026
Q1 | $11.7M | Sell |
53,617
-629
| -1% | -$140K | 0.65% | 20 |
|
|
2025
Q4 | $12.4M | Sell |
54,246
-77
| -0.1% | -$17.5K | 0.67% | 17 |
|
|
2025
Q3 | $12.6M | Buy |
54,323
+79
| +0.1% | +$16.1K | 0.73% | 17 |
|
|
2025
Q2 | $10.1M | Sell |
54,244
-4,280
| -7% | -$795K | 0.63% | 16 |
|
|
2025
Q1 | $12.3M | Sell |
58,524
-9
| -0% | -$1.75K | 0.87% | 14 |
|
|
2024
Q4 | $10.4M | Sell |
58,533
-2,932
| -5% | -$539K | 0.73% | 15 |
|
|
2024
Q3 | $12.1M | Buy |
61,465
+6,578
| +12% | +$1.23M | 0.93% | 13 |
|
|
2024
Q2 | $9.41M | Sell |
54,887
-8,162
| -13% | -$1.35M | 0.77% | 13 |
|
|
2024
Q1 | $11.5M | Buy |
63,049
+7,144
| +13% | +$1.23M | 0.92% | 14 |
|
|
2023
Q4 | $8.66M | Buy |
55,905
+603
| +1% | +$87.9K | 0.89% | 13 |
|
|
2023
Q3 | $8.24M | Buy |
55,302
+3,394
| +7% | +$498K | 0.93% | 13 |
|
|
2023
Q2 | $6.99M | Sell |
51,908
-209
| -0.4% | -$30.6K | 0.77% | 13 |
|
|
2023
Q1 | $8.31M | Sell |
52,117
-85
| -0.2% | -$13K | 0.96% | 12 |
|
|
2022
Q4 | $8.44M | Buy |
52,202
+54
| +0.1% | +$8.28K | 0.95% | 12 |
|
|
2022
Q3 | $7M | Sell |
52,148
-2,488
| -5% | -$357K | 0.9% | 13 |
|
|
2022
Q2 | $8.37M | Sell |
54,636
-500
| -0.9% | -$76.4K | 0.98% | 14 |
|
|
2022
Q1 | $8.94M | Buy |
55,136
+16,445
| +43% | +$2.39M | 0.84% | 17 |
|
|
2021
Q4 | $5.24M | Buy |
38,691
+167
| +0.4% | +$19.7K | 0.62% | 22 |
|
|
2021
Q3 | $4.16M | Sell |
38,524
-2,940
| -7% | -$336K | 0.34% | 28 |
|
|
2021
Q2 | $4.67M | Sell |
41,464
-343
| -0.8% | -$38.6K | 0.37% | 24 |
|
|
2021
Q1 | $4.52M | Buy |
41,807
+26
| +0.1% | +$2.78K | 0.37% | 29 |
|
|
2020
Q4 | $4.48M | Buy |
41,781
+84
| +0.2% | +$8.07K | 0.37% | 25 |
|
|
2020
Q3 | $3.65M | Buy |
41,697
+3,267
| +9% | +$308K | 0.31% | 27 |
|
|
2020
Q2 | $3.77M | Sell |
38,430
-2,891
| -7% | -$255K | 0.48% | 19 |
|
|
2020
Q1 | $3.15M | Buy |
41,321
+315
| +0.8% | +$26.8K | 0.47% | 25 |
|
|
2019
Q4 | $3.63M | Sell |
41,006
-26
| -0.1% | -$2.16K | 0.4% | 28 |
|
|
2019
Q3 | $3.11M | Buy |
41,032
+41
| +0.1% | +$2.81K | 0.47% | 19 |
|
|
2019
Q2 | $2.98M | Hold |
40,991
| – | – | 0.48% | 23 |
|
|
2019
Q1 | $3.3M | Hold |
40,991
| – | – | 0.43% | 37 |
|
|
2018
Q4 | $3.78M | Hold |
40,991
| – | – | 0.5% | 29 |
|
|
2018
Q3 | $3.88M | Buy |
40,991
+700
| +2% | +$66.4K | 0.56% | 19 |
|
|
2018
Q2 | $3.73M | Buy |
40,291
+36,070
| +855% | +$3.52M | 0.63% | 16 |
|
|
2018
Q1 | $400K | Buy |
+4,221
| New | +$464K | 0.07% | 62 |
|
|
2016
Q3 | – | Sell |
-4,150
| Closed | -$257K | – | 78 |
|
|
2016
Q2 | $257K | Buy |
+4,150
| New | +$253K | 0.04% | 60 |
|
Other funds holding ABBV
BBR Partners's ABBV Position: Q2 2026 in Review
BBR Partners reduced its AbbVie (ABBV) stake by 0% in Q2 2026, selling an estimated $430 and leaving 53,615 shares worth $13.5M. The position accounts for 0.63% of the portfolio, ranked #20.
BBR Partners first reported a position in ABBV in Q2 2016 and has held it in 35 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- BBR Partners held 53,615 shares of AbbVie worth $13.5M as of Q2 2026.
- BBR Partners sold 2 AbbVie shares in Q2 2026, an estimated $430.
- AbbVie made up 0.63% of BBR Partners's portfolio in Q2 2026, its #20 holding.
- BBR Partners first reported a position in AbbVie in Q2 2016 and has held it in 35 quarters since.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on BBR Partners's 13F filing for Q2 2026, filed 11 Aug 2026.